Bellerophon Therapeutics (BLPH) News Today $0.05 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 27 at 1:24 AM | americanbankingnews.comStockNews.com Initiates Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)July 21, 2024 | americanbankingnews.comBellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated at StockNews.comFebruary 25, 2024 | uk.finance.yahoo.comBellerophon Therapeutics, Inc. (BLPH)February 15, 2024 | investing.comBellerophon Therapeutics Inc (BLPH)January 31, 2024 | msn.comBellerophon Offers Series A Stock in Private SaleNovember 28, 2023 | benzinga.comHilco Streambank Seeks Offers to Acquire Patent Portfolio and Material Inventory of Biotherapeutics Company BellerophonNovember 2, 2023 | morningstar.comBellerophon Therapeutics Inc BLPHAugust 8, 2023 | finance.yahoo.comBLPH - Bellerophon Therapeutics, Inc.July 25, 2023 | msn.comWhat's Happening With Bellerophon Therapeutics Stock Today?July 25, 2023 | investorplace.comWhy Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?July 6, 2023 | msn.comBellerophon Therapeutics (BLPH) Price Target Decreased by 92.23% to 2.04June 6, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Bellerophon TherapeuticsJune 6, 2023 | finance.yahoo.comIs Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?June 6, 2023 | msn.comLaidlaw & Co. Downgrades Bellerophon Therapeutics (BLPH)June 6, 2023 | msn.comHC Wainwright & Co. Maintains Bellerophon Therapeutics (BLPH) Buy RecommendationJune 5, 2023 | msn.comBellerophon Therapeutics Stock Nosedive: Here's WhyJune 5, 2023 | msn.comWhy Is Bellerophon Therapeutics (BLPH) Stock Down 79% Today?June 5, 2023 | finance.yahoo.comBellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung DiseaseJune 5, 2023 | marketbeat.comTrading was temporarily halted for "BLPH" at 06:06 AM with a stated reason of "News pending."May 19, 2023 | msn.comLucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losersMay 19, 2023 | marketbeat.comHC Wainwright Brokers Increase Earnings Estimates for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)Bellerophon Therapeutics, Inc. (NASDAQ:BLPH - Get Rating) - Stock analysts at HC Wainwright lifted their Q2 2023 EPS estimates for Bellerophon Therapeutics in a report released on Wednesday, May 17th. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings perMay 17, 2023 | finance.yahoo.comBellerophon Therapeutics (NASDAQ:BLPH) delivers shareholders fantastic 978% return over 1 year, surging 18% in the last week aloneMay 16, 2023 | finanznachrichten.deBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial ResultsMay 15, 2023 | finance.yahoo.comBellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comBellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseaseApril 28, 2023 | finance.yahoo.comBellerophon Therapeutics (BLPH) Outpaces Stock Market Gains: What You Should KnowApril 24, 2023 | finance.yahoo.comBellerophon (BLPH) to Report Q1 Earnings: What's in the Cards?April 19, 2023 | finance.yahoo.comBellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should KnowApril 16, 2023 | marketbeat.comBellerophon Therapeutics, Inc. (NASDAQ:BLPH) Short Interest Down 40.8% in MarchBellerophon Therapeutics, Inc. (NASDAQ:BLPH - Get Rating) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 559,800 shares, a decline of 40.8% from the March 15th total of 945,100 shares. Based on an average trading volume of 1,210,000 shares, the days-to-cover ratio is presently 0.5 days.April 13, 2023 | msn.comBellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should KnowApril 4, 2023 | msn.comHC Wainwright & Co. Reiterates Bellerophon Therapeutics (BLPH) Buy RecommendationApril 4, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Bellerophon (BLPH)April 3, 2023 | finance.yahoo.comWhen Will Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Turn A Profit?April 2, 2023 | seekingalpha.comBellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06March 31, 2023 | finanznachrichten.deBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial ResultsMarch 31, 2023 | finance.yahoo.comBellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial ResultsMarch 28, 2023 | finance.yahoo.comBellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's WhyMarch 10, 2023 | finance.yahoo.comHere's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep goingMarch 6, 2023 | baystreet.caBellerophon to Buy Rival Firm’s SharesMarch 6, 2023 | markets.businessinsider.comBellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional InvestorMarch 6, 2023 | finance.yahoo.comBellerophon Therapeutics Announces $5 Million Registered Direct OfferingFebruary 9, 2023 | finance.yahoo.comBellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung DiseaseJanuary 18, 2023 | finance.yahoo.comBellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung DiseaseJanuary 6, 2023 | benzinga.comHow Is The Market Feeling About Bellerophon Therapeutics?January 6, 2023 | benzinga.comShort Volatility Alert: Bellerophon TherapeuticsJanuary 6, 2023 | finance.yahoo.comCompanies Like Bellerophon Therapeutics (NASDAQ:BLPH) Could Be Quite RiskyJanuary 5, 2023 | finance.yahoo.comBellerophon Therapeutics Shares Gained Over 200% TodayNovember 14, 2022 | finanznachrichten.deBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial ResultsNovember 14, 2022 | finance.yahoo.comBellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial ResultsSeptember 28, 2022 | finance.yahoo.comBellerophon (BLPH) Receives FDA Acceptance to Reduce Study Size Get Bellerophon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here BLPH Media Mentions By Week BLPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLPH News Sentiment▼0.000.62▲Average Medical News Sentiment BLPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLPH Articles This Week▼20▲BLPH Articles Average Week Get Bellerophon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NLS Pharmaceutics News InMed Pharmaceuticals News Phio Pharmaceuticals News NovaBay Pharmaceuticals News ASLAN Pharmaceuticals News Virpax Pharmaceuticals News Altamira Therapeutics News 180 Life Sciences News Tonix Pharmaceuticals News PaxMedica News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellerophon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.